StockData

Integra LifeSciences vs Teleflex

IART and TFX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IART and TFX compare

Teleflex is the larger company, worth 6.4 times as much as Integra LifeSciences ($6.8B against $1.1B).

Teleflex grew revenue faster over the last twelve months (30.7% versus 0.84% for Integra LifeSciences).

Integra LifeSciences keeps more of each dollar of sales as profit, with a net margin of 0.79% compared with −45.8% at Teleflex.

Teleflex pays a dividend yielding 0.64%; Integra LifeSciences does not pay one.

Integra LifeSciences scores higher on the StockData Score (9 against 7 for Teleflex), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIARTTFX
Size and price
Market cap$1.1B$6.8B
Share price$13.55$159.55
Change, 1 year15.3%49.1%
Change, 5 years−79.1%−47.7%
Beta (5Y)1.910.35
Employees3,70016K
StockData Score
Total score9 (better)7
Valuation score3 (better)1
Growth score2 (better)1
Performance score3 (better)1
Health score11
Dividend score03 (better)
Valuation
P/E79.7×–
P/S0.6× (better)3.0×
P/B1.0× (better)2.3×
EV/EBITDA10.2× (better)48.1×
P/FCF12.3× (better)40.1×
FCF yield8.1% (better)2.5%
Fair value$14.78$37.56
Margin of safety8.3% (better)−325%
Growth
Revenue growth (TTM)0.84%30.7% (better)
Revenue growth, 5Y average3.6% (better)−4.7%
Net income growth (TTM)–−638%
EPS growth (TTM)–−645%
Profitability
Gross margin52.4%54.9% (better)
Operating margin4.4% (better)2.0%
Net margin0.79% (better)−45.8%
FCF margin5.2%7.5% (better)
Return on equity1.2% (better)−28.9%
Return on invested capital5.6% (better)0.62%
Financial health
Debt / equity–0.97
Net debt / EBITDA–13.01
Interest coverage0.8× (better)0.4×
Current ratio3.62 (better)2.60
Altman Z-score1.271.60 (better)
Piotroski F-score55
Dividends and buybacks
Dividend yield–0.64%
Years of dividend growth–0
Dividend growth, 5Y average–0.00%
Buyback yield–3.7%
Shareholder yield0.00%4.3% (better)
Ownership
Held by institutions94.4%113%
Held by insiders3.4%0.73%
Insider net buying, 12 months$0–
Superinvestors holding–1
Short interest, % of float10.5%9.7%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.